Patient-derived parathyroid organoids (PTOs) could pave the way for future physiology studies and drug-screening applications, as shown in a new study. Patient-derived parathyroid organoids (PTOs) ...

Background A 54-year-old man presented to the emergency department of his local hospital with a 1-year history of fatigue, weight loss, and constipation. He had abused alcohol for many years, and his ...

September 19, 2007--Cinacalcet ( Sensipar, Amgen) may emerge as an important new therapeutic option for patients with inoperable parathyroid carcinoma, researchers report. According to the results of ...

Primary hyperparathyroidism is associated with increased long-term risks for hypertension, type 2 diabetes, and cardiovascular disease.

Secondary hyperparathyroidism is a complex endocrine condition characterized by excess circulating parathyroid hormone (PTH) resulting from an underlying condition, most commonly chronic kidney ...

Some people with hyperparathyroidism may notice weight gain or weight loss. These changes may occur due to factors like underlying medical conditions or appetite changes. Hyperparathyroidism is ...

July 14, 2011 (Prague, Czech Republic) — Paricalcitol was superior to cinacalcet in achieving target parathyroid hormone (PTH) levels in patients with secondary hyperparathyroidism (SHPT), a ...

Multiple endocrine neoplasia type 2 (MEN2) is a rare hereditary disorder that affects the endocrine glands. Doctors mainly associate MEN2 with tumors of the adrenal gland, the thyroid, and the ...

A 72-year-old woman presented with a sudden onset of pain, swelling and bruising of her neck that had occurred two days prior to presentation. A large bruise was observed over her neck (anterior and ...